The Use of Quantitative Histological and Molecular Data for Risk Assessment and Biologically Based Model Development

Toxicologic Pathology

Volumn 30, Issue 1, 2002, Pages 106-111

  Andersen, Melvin E ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

2,3,7,8 tetrachlorodibenzo p dioxin; cell proliferation; dioxin; immunohistochemistry; phenotypic switching; regional induction; Tumor promotion

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; CYTOCHROME P450; PROTEIN; TUMOR PROMOTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BIOCHEMISTRY; BIOLOGICAL MODEL; CELL POPULATION; CELL PROLIFERATION; CELL TYPE; CONTROLLED STUDY; DATA ANALYSIS; DOSE RESPONSE; HISTOPATHOLOGY; LIVER CELL; MOLECULAR BIOLOGY; MOLECULAR MECHANICS; MOLECULAR MODEL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; RAT; RISK ASSESSMENT;

ANIMALS; CARCINOGENS; DIOXINS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; PATHOLOGY; RISK ASSESSMENT;

ANIMALIA;

EID: 0036192161     PISSN: 01926233     EISSN: None     Source Type: Journal    
DOI: 10.1080/01926230252824789     Document Type: Article

References (29)

1. Andersen ME, Birnbaum LS, Barton HA, Eklund C. (1997). Regional hepatic CYP1A1 and CYP1A2 induction with 2,3,7,8-tetrachlorodibenzo -p-dioxin evaluated with a multi-compartment geometric model of hepatic zonation. ToxicolApplPharmacoll 44: 145-155.
2. Andersen ME, Conolly RB (1998). Mechanistic modeling of rodent liver tumor promotion at low levels of exposure: An example related to dose-response relationships for 2,3,7,8-tetrachlorodibenzo-p-dioxin. BELLE Newsletter 7: 2-8.
3. Andersen ME, Mills JJ, Gargas ML, Kedderis L., Birnbaum LS, Neubert D., Greenlee WF (1993). Modeling receptor-mediated processes with dioxin: Implications for pharmacokinetics and risk assessment. J Risk Anal 13: 25-36.
4. Andersen ME, Mills JJ, Jirtle RL, Greenlee WF (1995). Negative selection in hepatic tumor promotion in relation to cancer risk assessment. Toxicology 102: 223-237.
5. Bars RG, Elcombe CR (1991). Dose-dependent acinar induction of cytochrome P450 in rat liver. Evidence for a differential mechanism of induction of P450IA1 by b-naphthoflavone and dioxin. Biochem J 277: 577-580.
6. Bars RG, Mitchell AM, Wolf CR, Elcombe CR (1989). Induction of cytochrome P-450 in cultured hepatocytes. The heterogeneous localization of specificisoenzymes using immunocytochemistry. Biochem J 262: 151-158.
7. Bell DR, Bars RG, Gibson GG, Elcombe CR (1991). Localization and differential induction of cytochrome P450IVa and acyl-CoA oxidase in rat liver. Biochem J 275: 247-252.
8. Conolly RB, Andersen ME (1997). Hepatic foci in rats after diethylnitrosamine initiation and 2,3,7,8-tetrachlorodibenzo-p-dioxin promotion: Evaluation of a quantitative two-cell model and of CYP 1A1/1A2 as a dosimeter. Toxicol Appl Pharmacol 146: 281-293.
9. Conolly RB, Kimbell JS (1994). Computer simulation of cell growth governed by stochastic processes: Application to clonal growth cancer models. Toxicol Appl Pharmacol 124: 284-295.
10. Hall JC (1990). Genetics of circadian rhythms. Annu Rev Genet 24: 659-687.
11. Jirtle RL, Hankins GR, Reisenbichier H., Boyer IJ (1994). Regulation of mannose-6-phosphate/insulin-like growth factor-II receptors and transforming growth factor beta during liver tumor promotion with phenobarbital. Carcinogenesis 15: 1473-1478.
12. Jirtle RL, Meyer SA, Brockenbrough JS (1991). Liver tumor promoter phenobarbital: A biphasic modulator of hepatocyte proliferation. In: Chemically Induced Cell Proliferation: Implications for Risk Assessment. Wiley-Liss Inc, New York, pp 209-216.
13. Kociba RJ, Keyes DG, Beyer JE, Carreon RM, Wade CE, Dittenber DA, Kalnins RP, Frauson LE, Park CN, Banard SD, Hummel RA, Humiston CG (1978). Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo -p-dioxin in rats. Toxicol Appl Pharmacol 46: 279-303.
14. Kohn MC, Lucier GW, Clark GC, Sewall C., Tritscher A., Portier CJ (1993). A mechanistic model of the effects of dioxin on gene expression in the rat liver. Toxicol Appl Pharmacol 120: 138-154.
15. Lamers WH, Hilberts A., Furt E., Smith J., Jonges GN, Noorden CJFv, Gaasbeck-Janzen JW, Charles B., Moorman AFM (1989). Hepatic enzymic zonation: A reevaluation of the concept of the liver acinus. Hepatology 10: 72-76.
16. Leung HW, Paustenbach DJ, Murray FJ, Andersen ME (1990). Aphysiological pharmacokinetic description of the tissue distribution and enzyme inducing properties of 2,3,7,8-tetrachlorodibenzo -p-dioxin in the rat. Toxicol Appl Pharmacol 103: 399-410.
17. Maronpot RR, Foley JF, Takahashi K., Goldsworthy T., Clark G., Tritscher A., Portier C., Lucier G. (1993). Dose response for TCDD promotion of hepatocarcinogenesi s in rats initiated with DEN: Histologic, biochemical, and cell proliferation endpoints. Environ Health Perspect 101: 634-642.
18. McGrath LF, Cooper KR, Georgopoulos P., Gallo MA (1995). Alternative models for low dose-response analysis of biochemical and immunological endpoints for tetrachlorodibenzo-p-dioxin. Regul Toxicol Pharmacol 21: 382-396.
19. Ohno K., Ammann P, Fasciati R., Maier P (1995). Transforming growth factor b1 preferentially induces apoptotic cell death in rat hepatocytes cultured under pericentral-equivalent conditions. Toxicol Appl Pharmacol 132: 227-236.
20. Perdew GH (1992). Chemical cross-linking of the cytosolic and nuclear forms of the Ah receptor in hepatoma cell lines lele7. Biochem Biophys Res Comm 182: 55-62.
21. Pitot HC, Goldsworthy TL, Moran S., Kennan W., Glauert HP, Maronpot RR, Campbell HA (1987). A method to quantitate the relative initiating and promoting potencies of hepatocarcinogeni c agents in their dose-response relationships to altered hepatic foci. Carcinogenesis 8: 1491-1499.
22. Poland A., Knudson JC (1982). 2,3,7,8-Tetrachlorodibenzo -p-dioxin and related halogenated aromatic hydrocarbons: Examination of the mechanism of toxicity. Annu Rev Pharmacol Toxicol 32: 531-554.
23. Portier C., Tritscher A., Kohn M., Sewall C., Clark G., Edler L., Hoel D., Lucier G. (1993). Ligand/receptor binding for 2,3,7,8-TCDD: Implications for risk assessment. Fundam Appl Toxicol 20: 48-56.
24. Reyes H., Reisz-Porszasz S., Hankinson O. (1992). Identification of the Ah receptor nuclear translocator protein (Arnt) as a component of the DNA binding form of the Ah receptor. Science 256: 1193-1195.
25. Sarangapani RJ, Teeguarden Plotzke KP, McKim JE Jr, Andersen ME (2001). Dose-response modeling of cytochrome P450 induction in rats by octamethylcyclotetrasiloxane. Toxicol Sci., submitted.
26. Sutter TR, Greenlee WF (1992). Classification of members of the AH gene battery. Chemosphere 25: 222-226.
27. Tritscher AM, Goldstein JA, Portier CJ, McCoy Z., Clark GC, Lucier GW (1992). Dose-response relationships for chronic exposure to 2,3,7, 8-tetrachlorodibenzo-p-dioxin in a rat tumor promotion model: Quantification and immunolocalization of CYP1A1 and CYP1A2 in the liver. Cancer Res 52: 3436-3442.
28. Waxman DJ (1999). P450 gene induction by structurally diverse xenochemicals: Central role of nuclear receptors CAR, PXR, andPPAR. Arch Biochem Biophys 369: 11-23.
29. Whitlock JP (1990). Genetic and molecular aspects of 2,3,7,8-tetrchlorodibenzo-p-dioxin activity. Annu Rev Pharmacol Toxicol 30: 251-277.